Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-17
DOI
10.1186/s12879-020-05212-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients
- (2019) Nassim Kamar et al. HEPATOLOGY
- Viral Hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice
- (2019) Helen Te et al. CLINICAL TRANSPLANTATION
- Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study
- (2019) Nassim Kamar et al. CLINICAL INFECTIOUS DISEASES
- Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective
- (2018) Eve Todesco et al. ANTIVIRAL THERAPY
- EASL Clinical Practice Guidelines on hepatitis E virus infection
- (2018) Harry R. Dalton et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Ribavirin eradication of refractory hepatitis E in an immunosuppressed kidney transplant recipient
- (2018) Mary Drinane et al. HEPATOLOGY
- Hepatitis E virus infection in heart transplant recipients, Southeastern France
- (2018) Léa Luciani et al. Clinics and Research in Hepatology and Gastroenterology
- Sofosbuvir and Daclatasvir Anti–Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient
- (2017) Mhairi C. Donnelly et al. GASTROENTEROLOGY
- Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report
- (2017) R. Nakano et al. TRANSPLANTATION PROCEEDINGS
- Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity
- (2016) Yannick Debing et al. JOURNAL OF HEPATOLOGY
- Hepatitis E Seroprevalence in Europe: A Meta-Analysis
- (2016) Johannes Hartl et al. Viruses-Basel
- Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy
- (2015) Sebastien Lhomme et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis E: when to treat and how to treat
- (2013) Zaigham Abbas et al. ANTIVIRAL THERAPY
- Hepatitis E virus infection
- (2013) Nassim Kamar et al. CURRENT OPINION IN GASTROENTEROLOGY
- Clinical implications of chronic hepatitis E virus infection in heart transplant recipients
- (2012) Ludi Koning et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pegylated Interferon‐α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation
- (2010) Nassim Kamar et al. CLINICAL INFECTIOUS DISEASES
- Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients
- (2010) Nazia Selzner et al. JOURNAL OF HEPATOLOGY
- Reply: Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?
- (2009) Elizabeth B. Haagsma LIVER TRANSPLANTATION
- Chronic Hepatitis E with Cirrhosis in a Kidney-Transplant Recipient
- (2008) René Gérolami et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started